1-(5-methyl-1,2-oxazole-3-carbonyl)-N-[(2-methylphenyl)-(3-methyl-2-pyridinyl)methyl]piperidine-4-carboxamide
C25H28N4O3 — CID 126474586
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(5-methyl-1,2-oxazole-3-carbonyl)-N-[(2-methylphenyl)-(3-methyl-2-pyridinyl)methyl]piperidine-4-carboxamide
1-(5-methyl-1,2-oxazole-3-carbonyl)-N-[(2-methylphenyl)-(3-methyl-2-pyridinyl)methyl]piperidine-4-carboxamide (PubChem CID 126474586) has the molecular formula C25H28N4O3 and a molecular weight of 432.52 g/mol. Its IUPAC name is 1-(5-methyl-1,2-oxazole-3-carbonyl)-N-[(2-methylphenyl)-(3-methyl-2-pyridinyl)methyl]piperidine-4-carboxamide.
Molecular Properties
| Compound Name | 1-(5-methyl-1,2-oxazole-3-carbonyl)-N-[(2-methylphenyl)-(3-methyl-2-pyridinyl)methyl]piperidine-4-carboxamide |
|---|---|
| PubChem CID | 126474586 |
| Molecular Formula | C25H28N4O3 |
| Molecular Weight | 432.52 g/mol |
| Exact Mass | 432.22 |
| IUPAC Name | 1-(5-methyl-1,2-oxazole-3-carbonyl)-N-[(2-methylphenyl)-(3-methyl-2-pyridinyl)methyl]piperidine-4-carboxamide |
| SMILES | Cc1cc(C(=O)N2CCC(C(=O)NC(c3ccccc3C)c3ncccc3C)CC2)no1 |
| InChI | InChI=1S/C25H28N4O3/c1-16-7-4-5-9-20(16)23(22-17(2)8-6-12-26-22)27-24(30)19-10-13-29(14-11-19)25(31)21-15-18(3)32-28-21/h4-9,12,15,19,23H,10-11,13-14H2,1-3H3,(H,27,30) |
| InChIKey | BWWIQXUQYXBQMU-UHFFFAOYSA-N |
| XLogP | 3.75 |
| TPSA | 88.33 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 432.52 |
| LogP ≤ 5 | 3.75 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 126474586 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.